A Phase 2 Study of Vorinostat (Suberoylanilide Hydroxamic Acid, SAHA) in Relapsed or Refractory Indolent Non-Hodgkin Lymphoma. A California Consortium Study
Mark Kirschbaum, MD
Systemic Therapy Utilization Patterns among US Dermatologists and Oncologists Treating Cutaneous T-Cell Lymphoma
Lauren Pinter-Brown, MD, FACP
Randomized Phase III Trial of Pixantrone Compared with Other Chemotherapeutic Agents for Third-Line Single-Agent Treatment of Relapsed Aggressive Non-Hodgkin's Lymphoma
R Pettengell, G Narayanan, F H Mendoza, R Digumarti, H Gomez, H Gomez, P Cernohous, and I Gorbatchevsky